Literature DB >> 2167763

Inhibition of the amorphous calcium phosphate phase transformation reaction by polyphosphates and metal ions.

M J Root1.   

Abstract

The induction time for amorphous calcium phosphate (ACP) phase transformation was monitored at pH 7.4 and T = 25 degrees C with [Ca2+]o = [PO4]o = 4.0 X 10(-3) M, as a function of added crystal growth inhibitors Mg2+, Sr2+, Zn2+, pyrophosphate (PP), and tripolyphosphate (TPP). Metal ions increase the induction time for the initiation of the phase change reaction in the order Zn2+ less than Sr2+ less than Mg2+. For polyphosphates it was observed that both PP and TPP are potent inhibitors with TPP more effective than PP as expected. The combination of Mg2+ or Sr2+ and PP or TPP leads to a synergistic delay in the onset of the phase conversion. The greatest inhibition was observed for Mg2+ and TPP. Reaction solutions containing 2.0 X 10(-4) M Mg2+ and 4.0 X 10(-5) M TPP resulted in a 90% increase in the induction time over what would be anticipated from an additive effect from these species.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167763     DOI: 10.1007/BF02555994

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  21 in total

1.  Effect of magnesium on formation of calcium phosphate precipitates.

Authors:  M BOULET; J R MARIER; D ROSE
Journal:  Arch Biochem Biophys       Date:  1962-03       Impact factor: 4.013

2.  Factors affecting the precipitation of calcium phosphate in vitro.

Authors:  W G Robertson
Journal:  Calcif Tissue Res       Date:  1973-03-30

3.  Calcium phosphate formation in vitro. II. Effects of environment on amorphous-crystalline transformation.

Authors:  J D Termine; R A Peckauskas; A S Posner
Journal:  Arch Biochem Biophys       Date:  1970-10       Impact factor: 4.013

4.  An electron microscopic study of the formation of amorphous calcium phosphate and its transformation to crystalline apatite.

Authors:  E D Eanes; J D Termine; M U Nylen
Journal:  Calcif Tissue Res       Date:  1973-05-09

5.  In vitro and in vivo evaluation of anti-calculus agents.

Authors:  W W Briner; M D Francis
Journal:  Calcif Tissue Res       Date:  1973-01-25

6.  Comparative chemistry of amorphous and apatitic calcium phosphate preparations.

Authors:  J D Termine; E D Eanes
Journal:  Calcif Tissue Res       Date:  1972

7.  The inhibition of calcium hydroxypatite crystal growth by polyphosphonates and polyphosphates.

Authors:  M D Francis
Journal:  Calcif Tissue Res       Date:  1969

8.  Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.

Authors:  G Williams; J D Sallis
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

9.  Effects of EDITEMPA on dental calculus and caries formation in vivo.

Authors:  A Gaffar; E C Moreno; H R Muhlemann; H P Niles
Journal:  Calcif Tissue Int       Date:  1983-05       Impact factor: 4.333

10.  Formation and transformation of octacalcium phosphate, OCP: a preliminary report.

Authors:  R Z LeGeros; R Kijkowska; J P LeGeros
Journal:  Scan Electron Microsc       Date:  1984
View more
  3 in total

Review 1.  Modulation of bone calcium-binding sites regulates plasma calcium: an hypothesis.

Authors:  F Bronner; W D Stein
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

2.  Ethoxylated bisphenol dimethacrylate-based amorphous calcium phosphate composites.

Authors:  Drago Skrtic; Joseph M Antonucci; Da-Wei Liu
Journal:  Acta Biomater       Date:  2005-12-09       Impact factor: 8.947

3.  Glycochenodeoxycholic acid inhibits calcium phosphate precipitation in vitro by preventing the transformation of amorphous calcium phosphate to calcium hydroxyapatite.

Authors:  S M Qiu; G Wen; N Hirakawa; R D Soloway; N K Hong; R S Crowther
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.